Aurobindo Pharma Share Price in 2025: Chart, Monthly Trends, & Analysis
Advertisement
Aurobindo PharmaShare Price HistoryTomorrow TargetLong Term TargetDividend HistoryBonus HistorySplit History
How did Aurobindo Pharma shares perform in 2025?
Let's find out!
Aurobindo Pharma share price in 2025 was ₹1,171.59 Its price on 1st January 2025 was ₹1,334.85, and by 31st December 2025 it moved to ₹1,171.59, giving a negative return of -12.23% for the year.
Aurobindo Pharma Share Open, High, Low, and Close prices for the Year 2025 are as follows:
| Open | High | Low | Close |
|---|---|---|---|
| ₹1,334.85 | ₹1,356.2 | ₹1,010 | ₹1,171.59 |
| 1st Jan 2025 | Occured in Jan 2025 | Occured in Apr 2025 | 31st Dec 2025 |
This page will help you understand how Aurobindo Pharma performed in 2025. Let's get started.
For complete insights into Aurobindo Pharma’s incredible stock price performance and growth, see: Aurobindo Pharma Historical Share Price Data from its IPO to 2025
Table: Aurobindo Pharma Share Monthly Close, Low, High Prices for 2025
Advertisement
| Month | Aurobindo Pharma | Change% | ↑High - ↓Low |
|---|---|---|---|
| Jan | ₹1,171.9 | - | ↑ ₹1,356.2 ↓ ₹1,133.05 |
| Feb | ₹1,058.3 | -9.7% | ↑ ₹1,219.9 ↓ ₹1,052.7 |
| Mar | ₹1,160.5 | 9.6% | ↑ ₹1,230.7 ↓ ₹1,031.05 |
| Apr | ₹1,171.59 | 0.9% | ↑ ₹1,267.3 ↓ ₹1,010 |
Chart: CandleStick and Line Chart Showing Monthly Prices
[Click on line name to show/hide a line]
What if You invested ₹10,000 in Aurobindo Pharma in 2025?
In 2025, the opening price of Aurobindo Pharma share was ₹1334.85. Today, the price stands at ₹1,171.59, reflecting a growth of -12.23%. If we applying the same growth to your investment of ₹10,000 then, your investment of ₹10,000 in 2025 would have become ₹8,777.01 by 2025. This represents a CAGR of -12.23%.
You might also like to check: Aurobindo Pharma Stock Price in 2024
References:
Stock prices on stockpricearchive.com are gathered from reliable sources only. We take prices from stock exchanges only, majorly from BSE and NSE.
Disclaimer: Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.
